Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.

NCT00001730 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Hypothyroidism
Thyroid Neoplasms

Interventions

DRUG: Thyrogen

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)